About Orion

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being.

We believe that health and well-being create the foundation for a good life and society. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Our products are available in over one hundred countries.

We are continuously developing new drugs and treatment methods. The core therapy areas of our pharmaceutical R&D are oncology and pain.

We collaborate closely with healthcare professionals and leading global research institutions and pharmaceutical companies.

Science

Orion’s research and development has a long history with top expert professionals in the field. Today Orion’s pharmaceutical R&D focuses on pain and oncology. Orion also develops veterinary and generic drugs.

The focus areas of our research

Sustainability

Sustainability and ethics are vital for Orion and we demand a lot from ourselves and our partners in these areas. Our operations help to build the well-being of people, animals and society. At the same time, we strive to minimise the impact of our operations on the environment.

Where we are

Orion has more than 3,600 employees around the world. Our products are sold in over one hundred countries.

History

Orion was founded in 1917 by three pharmacists. Over the course of a century, we have developed into a globally operating company that carries out pharmaceutical research at top international level.

Strategy and purpose: The road is open for growth through well-being

By the 2030s, Orion will be a truly global, innovative, and patient-focused pharmaceutical company that serves societies and helps change patients’ lives across the globe.

NOVEMBER 2024 / CORP-208a(3)

Our locations

Visit global site 

What are you looking for?